News

Manipal Hospitals acquires regional provider Sahyadri for ~ $700 million

After months of negotiations, Manipal has finalised the acquisition of Sahyadri Hospitals for an estimated $800 million, marking a major shift in the ongoing consolidation of India’s for-profit hospital sector.

July 10, 2025

Bupa agrees to pay A$35m to Australians whose claims it wrongly rejected

British multinational health insurer Bupa has been forced by Australia’s Competition and Consumer Commission to pay A$35 million (~$23 million USD) to Australian insurance customers whose claims for hospital care it wrongly rejected.

July 10, 2025

UK CMA investigating Assura/PHP merger

The UK’s Competition and Markets Authority (CMA) is investigating the proposed merger between Assura and Primary Healthcare Properties (PHP), two listed UK REITs focused on primary care assets.

July 10, 2025

Interview: Dr Andrew Whiteley, Lexacom

Lexacom is a UK-based company that provides AI-based scribe tools for clinicians to automate note-taking. This is a space with a lot of competition at the moment, with a lot of venture capital money funding new startups. However, with 25 years of experience under its belt, Lexacom has managed to achieve a dominant position in the UK market. HBI spoke to Dr Andrew Whiteley, the company’s founder, about what differentiates Lexacom from its numerous competitors, the NHS’ recent decision to require scribes to be certified as medical devices, and Lexacom’s growing international presence.

July 10, 2025

Swedish healthcare AI start-up Tandem Health raises $50m Series A

Tandem Health, a Stockholm-based start-up that provides AI-based tools to clinicians to reduce admin workload, has raised a $50 million Series A to fund its expansion.

July 3, 2025

Branded pharmaceuticals most vulnerable to US tariff threats, should it come into force

At the end of June, President Trump announced sector-specific tariffs would be imposed “very soon.” From 9 July, reciprocal tariffs of 11% to 50% will be reinstated unless trade deals are secured with the EU and around 60 other countries. While these tariffs span multiple sectors, they include pharmaceuticals as a key area. In a bid to avoid the most severe consequences, the EU is reportedly prepared to accept a 10% blanket tariff on exports, but only if this results in extended negotiations and potential relief from other sector-specific duties. EU trade commissioner Maroš Šefčovič is in Washington this week pushing for an agreement, with high-level meetings scheduled with Commerce Secretary Howard Lutnick and Treasury Secretary Scott Bessent. Although discussions are ongoing, any deal may come down to the wire.

July 3, 2025

Ant Group’s AI healthcare push in China: a growing direct-to-consumer opportunity for European investors

China’s expanding digital health sector, driven by advances in AI technology and rising consumer demand for virtual medical services, presents growing opportunities for European investors seeking to enter the market.

July 3, 2025

FREE BLOG Standout themes from HBI’s Asia report

We’re about to release a Special Report on healthcare investment in Asia. The report offers a comprehensive overview of the dynamics, trends and opportunities in the healthcare markets of eight hugely important countries in the region: China, India, South Korea, Thailand, Vietnam, Indonesia, Malaysia and the Philippines.

July 3, 2025

France’s CNAM pushes to regulate private returns: what does it mean and how will it affect for-profit healthcare groups?

With France’s healthcare market facing sweeping reforms and tightening reimbursement rules, asset prices have dropped, presenting a rare opportunity for private equity investors and foreign healthcare providers to enter at a discount, provided they can navigate a shifting landscape marked by consolidation, tighter margins and rising regulatory scrutiny.

July 2, 2025

Manipal leads bid amid private equity interest in India’s OTPP-backed Sahyadri Hospitals acquisition

The race to acquire Sahyadri Hospitals has intensified over the past few months, with US and European private equity firms competing alongside domestic hospital groups. For foreign investors, regulatory challenges and local partnerships remain essential, as private equity shifts from minority stakes to majority ownership amid ongoing sector consolidation.

July 2, 2025

Older posts

Newer posts

News

July 10, 2025

July 10, 2025

July 10, 2025

July 10, 2025

July 3, 2025

July 3, 2025

July 3, 2025

July 3, 2025

July 2, 2025

July 2, 2025

Our Services

Company

Resources

Our Services

Company

Resources

Find Us

Please wait while your search results are being generated.

Get a CLEAR picture on private healthcare services across Europe

Subscribe now to Healthcare Europa and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture on private healthcare services across Emerging Markets

Subscribe now to Healthcare Nova and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture of ALL the top players in 22 sectors across 34 countries

Subscribe now to the only database of the Top 1,700 operators in Europe. Use it to:

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Get a CLEAR picture of the Top 1,300 players in Emerging Markets

Subscribe now to the only database of the Top 1,300 private healthcare operators in Emerging Markets . Use it to:

check

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Know the pulse of the market
from just £1040.

Know the pulse of the market
from just £1040.

Subscribe now to the only database of the
Top 1,700 operators in Europe. Use it to:

Instant access plus ongoing updates
from £1,895.

Subscribe now to the only database of the Top 1,300 private
healthcare operators in Emerging Markets . Use it to:

Instant access plus ongoing updates
from £1,895.